Skip to main content

Nonprofit · EIN 13-6272085

CANCER RESEARCH & TREATMENT FUND INC

Tax-exempt · NEW YORK, NY 10162

Financials

$1M$1M2023$1.1M$1M2024$880K$1.1M2025
Revenue Expenses · by fiscal year end
Financials of CANCER RESEARCH & TREATMENT FUND INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$879,584$1,054,997-$175,413$16,728,397$403,119$16,325,278
December 31, 2024990$1,146,870$1,004,872$141,998$15,194,701$301,193$14,893,508
December 31, 2023990$1,026,414$1,011,255$15,159$13,748,310$355,903$13,392,407
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$837,935
Program service revenue
$0
Investment income
$201,628
Net gain from sales of assets
$779
Net income from fundraising events
-$159,979
Other revenue
-$159,979

Expenses

Grants and similar amounts paid
$603,523
Compensation of officers, directors and key employees
$80,000
Other salaries and wages
$173,738
Salaries, compensation and benefits (total)
$275,911
Professional fundraising fees
$0
Accounting fees
$15,930
Occupancy
$48,334
Program services (functional)
$845,505
Management and general (functional)
$64,460
Fundraising (functional)
$145,032

Balance sheet and other

Total assets, start of year
$15,194,701
Total assets, end of year
$16,728,397
Total liabilities, end of year
$403,119
Net assets, end of year
$16,325,278
Publicly traded securities
$9,683,071
Net assets without donor restrictions
$16,325,278
Gross receipts
$1,725,231
Employees
4
Volunteers
40
Year formed
1968
State of legal domicile
NY

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
CHAD FEAYEMPLOYEE- ADMIN & DEVELOPMENT40$107,463
RICHARD T SILVERDIRECTOR EMERITUS40$80,000
MICHAEL GURTOWSKIVP-ADMIN & DEV.
Officer
40$26,833
DAVID BOULEDirector
Trustee or director, Officer
3$0
RICHARD ROSEDirector
Trustee or director
1$0
TODD SHAWDirector
Trustee or director
1$0
ADAM SILVERDirector
Trustee or director
1$0
CALEB SEXTONDirector
Trustee or director
1$0
JEFFREY PUGLISIMDDirector
Trustee or director
0$0
GHAITH ABU-ZEINAHDirector
Trustee or director
3$0
AMANDA JOHNS PEREZDirector
Trustee or director
1$0
RAJESH SHAHDirector
Trustee or director
1$0
TERRY HERMANSONDirector
Trustee or director
1$0
MICHAEL C KEMPNERDirector
Trustee or director
1$0
MARIA BRISBANEDirector
Trustee or director
1$0
6 more people on this return
NameTitleHours / weekCompensation
KASIA McCORMICKDirector
Trustee or director
1$0
NELSON BOXERDirector
Trustee or director, Officer
1$0
TIM SILVERDirector
Trustee or director
1$0
AJ SHIEKMANDirector
Trustee or director
1$0
THOMAS SILVERDirector
Trustee or director, Officer
3$0
ANNE TEMPLETONDirector
Trustee or director
1$0
990 for the year ended December 31, 2024: 18 people
NameTitleHours / weekCompensation
RICHARD TSILVER MDDirector
Trustee or director, Officer
40$120,000
DAVID BOULEDirector
Trustee or director, Officer
3$0
RICHARD ROSEDirector
Trustee or director
1$0
TODD SHAWDirector
Trustee or director
1$0
ADAM SILVERDirector
Trustee or director
1$0
CALEB SEXTONDirector
Trustee or director
1$0
JEFFREY PUGLISIMDDirector
Trustee or director
0$0
AMANDA JOHNS PEREZDirector
Trustee or director
1$0
RAJESH SHAHDirector
Trustee or director
1$0
TERRY HERMANSONDirector
Trustee or director
1$0
MICHAEL C KEMPNERDirector
Trustee or director
1$0
MARIA BRISBANEDirector
Trustee or director
1$0
KASIA McCORMICKDirector
Trustee or director
1$0
NELSON BOXERDirector
Trustee or director, Officer
1$0
TIM SILVERDirector
Trustee or director
1$0
AJ SHIEKMANDirector
Trustee or director
1$0
THOMAS SILVERDirector
Trustee or director, Officer
3$0
ANNE TEMPLETONDirector
Trustee or director
1$0
990 for the year ended December 31, 2023: 17 people
NameTitleHours / weekCompensation
RICHARD TSILVER MDDirector
Trustee or director, Officer
40$120,000
DAVID BOULEDirector
Trustee or director, Officer
3$0
RICHARD ROSEDirector
Trustee or director
1$0
TODD SHAWDirector
Trustee or director
1$0
ADAM SILVERDirector
Trustee or director
1$0
JEFFREY PUGLISIMDDirector
Trustee or director
0$0
AMANDA JOHNS PEREZDirector
Trustee or director
1$0
BHARAT SHAHDirector
Trustee or director
1$0
TERRY HERMANSONDirector
Trustee or director
1$0
MICHAEL C KEMPNERDirector
Trustee or director
1$0
MARIA BRISBANEDirector
Trustee or director
1$0
KASIA McCORMICKDirector
Trustee or director
1$0
NELSON BOXERDirector
Trustee or director, Officer
1$0
TIM SILVERDirector
Trustee or director
1$0
AJ SHIEKMANDirector
Trustee or director
1$0
THOMAS SILVERDirector
Trustee or director, Officer
3$0
ANNE TEMPLETONDirector
Trustee or director
1$0

Address and contacts

Address (IRS master file)
500 E 77TH ST APT 1001, NEW YORK, NY 10162-0015
Principal officer (990 for 2025)
THOMAS SILVER, 500 EAST 77TH STREET 1001, NEW YORK, NY 10162
Signed the 990
DAVID BOULE, Treasurer
Phone
(212) 288-6604
Return prepared by
J BRADLEY PC

Mission

CANCER RESEARCH AND TREATMENT FUND,INC.(CR&T) FUNDS RESEARCH EMPHASIZING THE CAUSE,PREVENTION,TREATMENT,AND CURE OF MYELOPROLIFERATIVE NEOPLASMS(MPNs)AND ALSOFUNDS OTHER BLOOD AND SOLID TUMOR CANCER RESEARCH.

990 for the year ended December 31, 2025

Program accomplishments

  • RESEARCH AND GRANTS MADE FOR CANCER CARE AND CURE.
    Expenses $845,505 · grants $603,523

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
13-6272085
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1968
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$16,728,397
Income (IRS master file)
$1,725,231

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$879,584$1,054,997$16,728,397XML
990December 2024$1,146,870$1,004,872$15,194,701XML
990December 2023$1,026,414$1,011,255$13,748,310XML
990December 2022$573,018$957,125$12,581,316IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 13-6272085).

Questions about CANCER RESEARCH & TREATMENT FUND INC

What is the EIN of CANCER RESEARCH & TREATMENT FUND INC?
The employer identification number (EIN) of CANCER RESEARCH & TREATMENT FUND INC is 13-6272085.
Is CANCER RESEARCH & TREATMENT FUND INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1968.
Are donations to CANCER RESEARCH & TREATMENT FUND INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does CANCER RESEARCH & TREATMENT FUND INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of CANCER RESEARCH & TREATMENT FUND INC due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CANCER RESEARCH & TREATMENT FUND INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of CANCER RESEARCH & TREATMENT FUND INC?
The 990 for the year ended December 31, 2025 names THOMAS SILVER.
Who are the officers and directors of CANCER RESEARCH & TREATMENT FUND INC?
The 990 for the year ended December 31, 2025 lists 21 people; 3 received compensation from the organization, the highest $107,463 (CHAD FEAY, EMPLOYEE- ADMIN & DEVELOPMENT).
How much revenue does CANCER RESEARCH & TREATMENT FUND INC have?
On its 990 for the year ended December 31, 2025 it reported revenue of $879,584, expenses of $1,054,997 and total assets of $16,728,397 at year end.

Other nonprofits in NEW YORK

All nonprofits in NEW YORK · New York